MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$57,351K
EPS
-$1.34
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
42,633
General and administrative
21,916
Total operating expenses
64,549
Income (loss) from operations
-64,549
Interest and investment income (expense)
6,380
Other income (expense)
730
Other income (expense), net
7,110
Net income (loss)
-57,439
Net unrealized gain (loss) on marketable debt securities
88
Other comprehensive income (loss)
88
Comprehensive income (loss)
-57,351
Basic EPS
-1.34
Diluted EPS
-1.34
Basic Average Shares
42,836,129
Diluted Average Shares
42,836,129
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net unrealized gain(loss) on marketable...$88K Comprehensive income (loss)-$57,351K Other comprehensiveincome (loss)$88K Interest and investmentincome (expense)$6,380K Other income(expense)$730K Net income (loss)-$57,439K Other income(expense), net$7,110K Income (loss) fromoperations-$64,549K Total operatingexpenses$64,549K Research and development$42,633K General andadministrative$21,916K

Protara Therapeutics, Inc. (TARA)

Protara Therapeutics, Inc. (TARA)